BNO 0.00% 1.0¢ bionomics limited

"Patient enrolment in BNC210 exploratory clinical trial to treat...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,385 Posts.
    lightbulb Created with Sketch. 283
    "Patient enrolment in BNC210 exploratory clinical trial to treat Agitation in elderly patients in a hospital/nursing home setting is now complete and top line data are expected by the end of June 2019."

    That's all I needed to hear.
 
watchlist Created with Sketch. Add BNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.